{
  "directed": true,
  "graph": {
    "annotation_curie": [],
    "annotation_list": {},
    "annotation_miriam": [],
    "annotation_pattern": {
      "Species": "^\\d+$"
    },
    "annotation_url": {
      "Anatomy": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/anatomy/anatomy-20170511.belanno",
      "Cell": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell/cell-20170511.belanno",
      "CellLine": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-line/cell-line-20170511.belanno",
      "CellStructure": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-structure/cell-structure-20170511.belanno",
      "Confidence": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/confidence/confidence-1.0.0.belanno",
      "Disease": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/disease/disease-20170511.belanno",
      "Gender": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/gender/gender-1.0.0.belanno",
      "MeSHAnatomy": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-anatomy/mesh-anatomy-20170511.belanno",
      "MeSHDisease": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-diseases/mesh-diseases-20170511.belanno"
    },
    "document_metadata": {
      "authors": "Trusha Adeshara",
      "contact": "charles.hoyt@scai.fraunhofer.de",
      "copyright": "Copyright Â© 2019 Fraunhofer Institute SCAI, All rights reserved.",
      "description": "",
      "licenses": "CC BY 4.0",
      "name": "Progressive multiple sclerosis: prospects for disease therapy, repair, and restoration of function",
      "version": "1.0.0"
    },
    "namespace_pattern": {
      "NCIT": "^C\\d+$",
      "PUBCHEM": "^\\d+$"
    },
    "namespace_url": {
      "CHEBI": "https://raw.githubusercontent.com/pharmacome/conso/c328ad964c08967a0417a887510b97b965a62fa5/external/chebi-names.belns",
      "CONSO": "https://raw.githubusercontent.com/pharmacome/conso/3c93a65dc48e6786fe29ae55aa36cf9a902fe8c6/export/conso-names.belns",
      "DOID": "https://raw.githubusercontent.com/pharmacome/conso/c0c576e3d3ab9b25a3982251a4ee2fd7c49e1679/external/doid-names.belns",
      "DRUGBANK": "https://raw.githubusercontent.com/pharmacome/conso/c328ad964c08967a0417a887510b97b965a62fa5/external/drugbank-names.belns",
      "EFO": "https://raw.githubusercontent.com/pharmacome/conso/5d2c2ea6f7112421cc8089a3f021a75ab60bb373/external/efo-names.belns",
      "GO": "https://raw.githubusercontent.com/pharmacome/conso/d9d270e11aac480542c412d4222983a5f042b8ae/external/go-names.belns",
      "HGNC": "https://raw.githubusercontent.com/pharmacome/conso/c328ad964c08967a0417a887510b97b965a62fa5/external/hgnc-names.belns",
      "HGNCGENEFAMILY": "https://raw.githubusercontent.com/pharmacome/conso/c328ad964c08967a0417a887510b97b965a62fa5/external/hgnc.genefamily-names.belns",
      "HP": "https://raw.githubusercontent.com/pharmacome/conso/d9d270e11aac480542c412d4222983a5f042b8ae/external/hp-names.belns",
      "INTERPRO": "https://raw.githubusercontent.com/pharmacome/conso/c328ad964c08967a0417a887510b97b965a62fa5/external/interpro-names.belns",
      "MESH": "https://raw.githubusercontent.com/pharmacome/conso/f02c6ad4a4791a8ed45448513b9de8c8f1b00c87/external/mesh-names.belns"
    },
    "path": "ms/ontaneda2016.bel",
    "pybel_version": "0.15.3"
  },
  "links": [
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "first": "Brownlee WJ",
        "identifier": "27889190",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "namespace": "pubmed",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "Patients with primary and secondary progressive multiple sclerosis exhibit gradually worsening disability, most often motor impairment with a pattern suggesting a myelopathy, but also progressive hemiparesis, ataxia, visual dysfunction, or cognitive impairment.",
      "key": "dc2316a4a531a3ffc0beb81b2952158e",
      "line": 79,
      "relation": "increases",
      "source": 35,
      "target": 52
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "first": "Brownlee WJ",
        "identifier": "27889190",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "namespace": "pubmed",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "Patients with primary and secondary progressive multiple sclerosis exhibit gradually worsening disability, most often motor impairment with a pattern suggesting a myelopathy, but also progressive hemiparesis, ataxia, visual dysfunction, or cognitive impairment.",
      "key": "0074bc86c1f1c367064d2a9666bf98bf",
      "line": 81,
      "relation": "increases",
      "source": 35,
      "target": 45
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "first": "Brownlee WJ",
        "identifier": "27889190",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "namespace": "pubmed",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "Patients with primary and secondary progressive multiple sclerosis exhibit gradually worsening disability, most often motor impairment with a pattern suggesting a myelopathy, but also progressive hemiparesis, ataxia, visual dysfunction, or cognitive impairment.",
      "key": "b5a7ded38de7104616812fff1e65df36",
      "line": 83,
      "relation": "increases",
      "source": 35,
      "target": 43
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "first": "Brownlee WJ",
        "identifier": "27889190",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "namespace": "pubmed",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "Patients with primary and secondary progressive multiple sclerosis exhibit gradually worsening disability, most often motor impairment with a pattern suggesting a myelopathy, but also progressive hemiparesis, ataxia, visual dysfunction, or cognitive impairment.",
      "key": "4d9ac76dc1d95fa0d1fbe3e5124f8f24",
      "line": 85,
      "relation": "increases",
      "source": 35,
      "target": 42
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "first": "Brownlee WJ",
        "identifier": "27889190",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "namespace": "pubmed",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "Patients with primary and secondary progressive multiple sclerosis exhibit gradually worsening disability, most often motor impairment with a pattern suggesting a myelopathy, but also progressive hemiparesis, ataxia, visual dysfunction, or cognitive impairment.",
      "key": "cbde0d76d212f1d8fbf5a954dd5b72ff",
      "line": 87,
      "relation": "increases",
      "source": 35,
      "target": 41
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "first": "Brownlee WJ",
        "identifier": "27889190",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "namespace": "pubmed",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "Patients with primary and secondary progressive multiple sclerosis exhibit gradually worsening disability, most often motor impairment with a pattern suggesting a myelopathy, but also progressive hemiparesis, ataxia, visual dysfunction, or cognitive impairment.",
      "key": "77e7f8f88036db40084055559f95a51b",
      "line": 89,
      "relation": "increases",
      "source": 35,
      "target": 47
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "first": "Brownlee WJ",
        "identifier": "27889190",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "namespace": "pubmed",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "Patients with primary and secondary progressive multiple sclerosis exhibit gradually worsening disability, most often motor impairment with a pattern suggesting a myelopathy, but also progressive hemiparesis, ataxia, visual dysfunction, or cognitive impairment.",
      "key": "f436d04de7d284c7f9da380bd7514520",
      "line": 91,
      "relation": "decreases",
      "source": 35,
      "target": 39
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "first": "Brownlee WJ",
        "identifier": "27889190",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "namespace": "pubmed",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "Patients with primary and secondary progressive multiple sclerosis exhibit gradually worsening disability, most often motor impairment with a pattern suggesting a myelopathy, but also progressive hemiparesis, ataxia, visual dysfunction, or cognitive impairment.",
      "key": "ddf9509d3b7f85a0cc86f2a7fe30abc0",
      "line": 80,
      "relation": "increases",
      "source": 38,
      "target": 52
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "first": "Brownlee WJ",
        "identifier": "27889190",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "namespace": "pubmed",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "Patients with primary and secondary progressive multiple sclerosis exhibit gradually worsening disability, most often motor impairment with a pattern suggesting a myelopathy, but also progressive hemiparesis, ataxia, visual dysfunction, or cognitive impairment.",
      "key": "bb519eb438933f03c8b1491b69b42fe7",
      "line": 82,
      "relation": "increases",
      "source": 38,
      "target": 45
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "first": "Brownlee WJ",
        "identifier": "27889190",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "namespace": "pubmed",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "Patients with primary and secondary progressive multiple sclerosis exhibit gradually worsening disability, most often motor impairment with a pattern suggesting a myelopathy, but also progressive hemiparesis, ataxia, visual dysfunction, or cognitive impairment.",
      "key": "323cc4653a2ec313cf71fc71d908f814",
      "line": 84,
      "relation": "increases",
      "source": 38,
      "target": 43
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "first": "Brownlee WJ",
        "identifier": "27889190",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "namespace": "pubmed",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "Patients with primary and secondary progressive multiple sclerosis exhibit gradually worsening disability, most often motor impairment with a pattern suggesting a myelopathy, but also progressive hemiparesis, ataxia, visual dysfunction, or cognitive impairment.",
      "key": "011aa3840fb9011960cd57b37d4e6ce1",
      "line": 86,
      "relation": "increases",
      "source": 38,
      "target": 42
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "first": "Brownlee WJ",
        "identifier": "27889190",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "namespace": "pubmed",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "Patients with primary and secondary progressive multiple sclerosis exhibit gradually worsening disability, most often motor impairment with a pattern suggesting a myelopathy, but also progressive hemiparesis, ataxia, visual dysfunction, or cognitive impairment.",
      "key": "5250d8b1cb7e4d92ee8a5921f57f0a39",
      "line": 88,
      "relation": "increases",
      "source": 38,
      "target": 41
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "first": "Brownlee WJ",
        "identifier": "27889190",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "namespace": "pubmed",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "Patients with primary and secondary progressive multiple sclerosis exhibit gradually worsening disability, most often motor impairment with a pattern suggesting a myelopathy, but also progressive hemiparesis, ataxia, visual dysfunction, or cognitive impairment.",
      "key": "5c3782bbef45f8a792110479a809c408",
      "line": 90,
      "relation": "increases",
      "source": 38,
      "target": 47
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "first": "Brownlee WJ",
        "identifier": "27889190",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "namespace": "pubmed",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "Patients with primary and secondary progressive multiple sclerosis exhibit gradually worsening disability, most often motor impairment with a pattern suggesting a myelopathy, but also progressive hemiparesis, ataxia, visual dysfunction, or cognitive impairment.",
      "key": "34e93efaa43d7894cc8a989e82663edb",
      "line": 92,
      "relation": "decreases",
      "source": 38,
      "target": 39
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "first": "Brownlee WJ",
        "identifier": "27889190",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "namespace": "pubmed",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "In the early stages, pathology is dominated by focal inflammatory lesions with perivenular accumulation of T and B lymphocytes, bloodâbrain barrier disruption, demyelination, and acute axonal transection.[5]",
      "key": "078133c8a5f156a5f3028bf5b98bfac8",
      "line": 97,
      "relation": "increases",
      "source": 34,
      "target": 14
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "first": "Brownlee WJ",
        "identifier": "27889190",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "namespace": "pubmed",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "In the early stages, pathology is dominated by focal inflammatory lesions with perivenular accumulation of T and B lymphocytes, bloodâbrain barrier disruption, demyelination, and acute axonal transection.[5]",
      "key": "3ea51113d3d2a213772c87925a93701d",
      "line": 98,
      "relation": "increases",
      "source": 34,
      "target": 15
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "first": "Brownlee WJ",
        "identifier": "27889190",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "namespace": "pubmed",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "In the early stages, pathology is dominated by focal inflammatory lesions with perivenular accumulation of T and B lymphocytes, bloodâbrain barrier disruption, demyelination, and acute axonal transection.[5]",
      "key": "e29c59ead61abcd052c701d4489b95a2",
      "line": 99,
      "relation": "increases",
      "source": 34,
      "target": 5,
      "target_modifier": {
        "modifier": "Degradation"
      }
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "first": "Brownlee WJ",
        "identifier": "27889190",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "namespace": "pubmed",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "In the early stages, pathology is dominated by focal inflammatory lesions with perivenular accumulation of T and B lymphocytes, bloodâbrain barrier disruption, demyelination, and acute axonal transection.[5]",
      "key": "21d568886fa8758f8a79e63758acd52d",
      "line": 100,
      "relation": "increases",
      "source": 34,
      "target": 40
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "first": "Brownlee WJ",
        "identifier": "27889190",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "namespace": "pubmed",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "In the early stages, pathology is dominated by focal inflammatory lesions with perivenular accumulation of T and B lymphocytes, bloodâbrain barrier disruption, demyelination, and acute axonal transection.[5]",
      "key": "931db20de86c7e2548d1cac6af07eef2",
      "line": 101,
      "relation": "association",
      "source": 34,
      "target": 20
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "Disease": [
          {
            "identifier": "progressive relapsing multiple sclerosis",
            "namespace": "Disease"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "first": "Brownlee WJ",
        "identifier": "27889190",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "namespace": "pubmed",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "The severity of cortical demyelination correlates with the extent of meningeal inflammation in progressive multiple sclerosis, suggesting a pathogenic role.[10]",
      "key": "16e52ccb9c7b3faf74b44d085709a296",
      "line": 126,
      "relation": "positiveCorrelation",
      "source": 40,
      "target": 49
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "first": "Brownlee WJ",
        "identifier": "27889190",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "namespace": "pubmed",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "In the early stages, pathology is dominated by focal inflammatory lesions with perivenular accumulation of T and B lymphocytes, bloodâbrain barrier disruption, demyelination, and acute axonal transection.[5]",
      "key": "2cb7a58dc35181f7b039195b1b65af34",
      "line": 101,
      "relation": "association",
      "source": 20,
      "target": 34
    },
    {
      "annotations": {
        "Anatomy": [
          {
            "identifier": "cerebellum",
            "namespace": "Anatomy"
          },
          {
            "identifier": "cortex",
            "namespace": "Anatomy"
          },
          {
            "identifier": "spinal cord",
            "namespace": "Anatomy"
          }
        ],
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "first": "Brownlee WJ",
        "identifier": "27889190",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "namespace": "pubmed",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "The clinical importance of grey matter pathology involving cortex, deep structures, cerebellum, and spinal cord is increasingly recognised in progressive multiple sclerosis.[7]",
      "key": "390a51fa66a40077168917f8f2a145fc",
      "line": 107,
      "relation": "association",
      "source": 36,
      "target": 6
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "first": "Brownlee WJ",
        "identifier": "27889190",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "namespace": "pubmed",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "Cortical histopathology includes microglial activation, demyelination, neuritic transection, neuronal death, and reduced presynaptic terminals, but tends not to include perivascular lymphocytic cuffs typical of white matter lesions.[8]",
      "key": "4d88ea66c44acda7a286271d74720584",
      "line": 114,
      "relation": "increases",
      "source": 36,
      "target": 16
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "first": "Brownlee WJ",
        "identifier": "27889190",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "namespace": "pubmed",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "Cortical histopathology includes microglial activation, demyelination, neuritic transection, neuronal death, and reduced presynaptic terminals, but tends not to include perivascular lymphocytic cuffs typical of white matter lesions.[8]",
      "key": "a40a53e400814693ece9a54b6a855b9f",
      "line": 115,
      "relation": "increases",
      "source": 36,
      "target": 40
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "first": "Brownlee WJ",
        "identifier": "27889190",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "namespace": "pubmed",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "Cortical histopathology includes microglial activation, demyelination, neuritic transection, neuronal death, and reduced presynaptic terminals, but tends not to include perivascular lymphocytic cuffs typical of white matter lesions.[8]",
      "key": "af8a72dbfd061fcc907726ba54cd6274",
      "line": 116,
      "relation": "association",
      "source": 36,
      "target": 10
    },
    {
      "annotations": {
        "Cell": [
          {
            "identifier": "neuron",
            "namespace": "Cell"
          }
        ],
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "first": "Brownlee WJ",
        "identifier": "27889190",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "namespace": "pubmed",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "Cortical histopathology includes microglial activation, demyelination, neuritic transection, neuronal death, and reduced presynaptic terminals, but tends not to include perivascular lymphocytic cuffs typical of white matter lesions.[8]",
      "key": "46ecbef13790e892a4f73000f2b0cb3b",
      "line": 118,
      "relation": "increases",
      "source": 36,
      "target": 21
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "first": "Brownlee WJ",
        "identifier": "27889190",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "namespace": "pubmed",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "Cortical histopathology includes microglial activation, demyelination, neuritic transection, neuronal death, and reduced presynaptic terminals, but tends not to include perivascular lymphocytic cuffs typical of white matter lesions.[8]",
      "key": "f5fb909103ec9d73a1058a982971863e",
      "line": 120,
      "relation": "decreases",
      "source": 36,
      "target": 7
    },
    {
      "annotations": {
        "CellStructure": [
          {
            "identifier": "Axons",
            "namespace": "CellStructure"
          }
        ],
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "first": "Brownlee WJ",
        "identifier": "27889190",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "namespace": "pubmed",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "Demyelinated axons are abundant in longstanding multiple sclerosis and are hypothesised to be susceptible to chronic injury.[6]",
      "key": "ba8f6668b07e72341aa98a9b2aa5fb6c",
      "line": 134,
      "relation": "increases",
      "source": 36,
      "target": 51
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "MeSHAnatomy": [
          {
            "identifier": "Caudate Nucleus",
            "namespace": "MeSHAnatomy"
          },
          {
            "identifier": "Hippocampus",
            "namespace": "MeSHAnatomy"
          },
          {
            "identifier": "Thalamus",
            "namespace": "MeSHAnatomy"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "first": "Brownlee WJ",
        "identifier": "27889190",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "namespace": "pubmed",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "Atrophy of deep grey structures (thalamus, caudate, and hippocampus) also occurs in progressive multiple sclerosis and can be focal (presumably due to lesions) or more diffuse (presumably due to damage to afferent or efferent connections).[29,30]",
      "key": "b227af9c5936aa1d4013af00ebd79c41",
      "line": 180,
      "relation": "increases",
      "source": 36,
      "target": 48
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "MeSHDisease": [
          {
            "identifier": "Multiple Sclerosis, Relapsing-Remitting",
            "namespace": "MeSHDisease"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "first": "Brownlee WJ",
        "identifier": "27889190",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "namespace": "pubmed",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "Cellular energy metabolism seems to be abnormal in progressive multiple sclerosis [11] and is another potential therapeutic target.",
      "key": "e3bdd948da674f787571418af98a19c9",
      "line": 206,
      "relation": "negativeCorrelation",
      "source": 36,
      "target": 22
    },
    {
      "annotations": {
        "Anatomy": [
          {
            "identifier": "cerebellum",
            "namespace": "Anatomy"
          },
          {
            "identifier": "cortex",
            "namespace": "Anatomy"
          },
          {
            "identifier": "spinal cord",
            "namespace": "Anatomy"
          }
        ],
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "first": "Brownlee WJ",
        "identifier": "27889190",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "namespace": "pubmed",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "The clinical importance of grey matter pathology involving cortex, deep structures, cerebellum, and spinal cord is increasingly recognised in progressive multiple sclerosis.[7]",
      "key": "732ef52bb2a8b378dc5f4f53c5bed3e1",
      "line": 107,
      "relation": "association",
      "source": 6,
      "target": 36
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "first": "Brownlee WJ",
        "identifier": "27889190",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "namespace": "pubmed",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "Cortical histopathology includes microglial activation, demyelination, neuritic transection, neuronal death, and reduced presynaptic terminals, but tends not to include perivascular lymphocytic cuffs typical of white matter lesions.[8]",
      "key": "c08d25f8d5ffa8002f6252a7b0a549bd",
      "line": 116,
      "relation": "association",
      "source": 10,
      "target": 36
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "Disease": [
          {
            "identifier": "progressive relapsing multiple sclerosis",
            "namespace": "Disease"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "first": "Brownlee WJ",
        "identifier": "27889190",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "namespace": "pubmed",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "The severity of cortical demyelination correlates with the extent of meningeal inflammation in progressive multiple sclerosis, suggesting a pathogenic role.[10]",
      "key": "dcc5772be66363fcc85007e9598510aa",
      "line": 126,
      "relation": "positiveCorrelation",
      "source": 49,
      "target": 40
    },
    {
      "annotations": {
        "CellStructure": [
          {
            "identifier": "Axons",
            "namespace": "CellStructure"
          }
        ],
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "first": "Brownlee WJ",
        "identifier": "27889190",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "namespace": "pubmed",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "In some demyelinated axons, saltatory nerve-impulse conduction is replaced by continuous conduction, which restores function but increases energy demand and sodium accumulation in the axonal cytoplasm. Resultant reverse operation of sodiumâcalcium exchanger to restore ionic gradients could lead to cytoplasmic calcium accumulation, activation of calpains, and proteolysis of cytoskeleton.",
      "key": "ee9f5fe60d3dedf670dd742b4846c9b1",
      "line": 139,
      "relation": "association",
      "source": 51,
      "target": 23
    },
    {
      "annotations": {
        "CellStructure": [
          {
            "identifier": "Axons",
            "namespace": "CellStructure"
          }
        ],
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "first": "Brownlee WJ",
        "identifier": "27889190",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "namespace": "pubmed",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "In some demyelinated axons, saltatory nerve-impulse conduction is replaced by continuous conduction, which restores function but increases energy demand and sodium accumulation in the axonal cytoplasm. Resultant reverse operation of sodiumâcalcium exchanger to restore ionic gradients could lead to cytoplasmic calcium accumulation, activation of calpains, and proteolysis of cytoskeleton.",
      "key": "f4574d5452caf8d4ba8d4b7ac5cde639",
      "line": 140,
      "relation": "increases",
      "source": 51,
      "target": 22
    },
    {
      "annotations": {
        "CellStructure": [
          {
            "identifier": "Axons",
            "namespace": "CellStructure"
          }
        ],
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "first": "Brownlee WJ",
        "identifier": "27889190",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "namespace": "pubmed",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "In some demyelinated axons, saltatory nerve-impulse conduction is replaced by continuous conduction, which restores function but increases energy demand and sodium accumulation in the axonal cytoplasm. Resultant reverse operation of sodiumâcalcium exchanger to restore ionic gradients could lead to cytoplasmic calcium accumulation, activation of calpains, and proteolysis of cytoskeleton.",
      "key": "0eb85e98de2cb7b28d81dec80837ccea",
      "line": 141,
      "relation": "increases",
      "source": 51,
      "target": 13,
      "target_modifier": {
        "location": {
          "name": "axon cytoplasm",
          "namespace": "GO"
        }
      }
    },
    {
      "annotations": {
        "CellStructure": [
          {
            "identifier": "Axons",
            "namespace": "CellStructure"
          }
        ],
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "first": "Brownlee WJ",
        "identifier": "27889190",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "namespace": "pubmed",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "In some demyelinated axons, saltatory nerve-impulse conduction is replaced by continuous conduction, which restores function but increases energy demand and sodium accumulation in the axonal cytoplasm. Resultant reverse operation of sodiumâcalcium exchanger to restore ionic gradients could lead to cytoplasmic calcium accumulation, activation of calpains, and proteolysis of cytoskeleton.",
      "key": "3246b3c83aa6349428f38fcf3c24c226",
      "line": 139,
      "relation": "association",
      "source": 23,
      "target": 51
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "MeSHDisease": [
          {
            "identifier": "Multiple Sclerosis, Relapsing-Remitting",
            "namespace": "MeSHDisease"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "first": "Brownlee WJ",
        "identifier": "27889190",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "namespace": "pubmed",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "Cellular energy metabolism seems to be abnormal in progressive multiple sclerosis [11] and is another potential therapeutic target.",
      "key": "edc988cae184e11291d61e6ab91bfaf6",
      "line": 206,
      "relation": "negativeCorrelation",
      "source": 22,
      "target": 36
    },
    {
      "annotations": {
        "CellStructure": [
          {
            "identifier": "Axons",
            "namespace": "CellStructure"
          }
        ],
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "first": "Brownlee WJ",
        "identifier": "27889190",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "namespace": "pubmed",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "In some demyelinated axons, saltatory nerve-impulse conduction is replaced by continuous conduction, which restores function but increases energy demand and sodium accumulation in the axonal cytoplasm. Resultant reverse operation of sodiumâcalcium exchanger to restore ionic gradients could lead to cytoplasmic calcium accumulation, activation of calpains, and proteolysis of cytoskeleton.",
      "key": "4fff6c4e3e7c6c21bfecb17ff2d6c427",
      "line": 142,
      "relation": "increases",
      "source": 13,
      "source_modifier": {
        "location": {
          "name": "axon cytoplasm",
          "namespace": "GO"
        }
      },
      "target": 31,
      "target_modifier": {
        "modifier": "Activity"
      }
    },
    {
      "key": "e36587ab9872d2d784c81d9a78ead04d",
      "relation": "partOf",
      "source": 13,
      "target": 27
    },
    {
      "key": "cdc989a5b67e3e7e621951fb257db6d3",
      "relation": "partOf",
      "source": 31,
      "target": 27
    },
    {
      "annotations": {
        "CellStructure": [
          {
            "identifier": "Axons",
            "namespace": "CellStructure"
          }
        ],
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "first": "Brownlee WJ",
        "identifier": "27889190",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "namespace": "pubmed",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "In some demyelinated axons, saltatory nerve-impulse conduction is replaced by continuous conduction, which restores function but increases energy demand and sodium accumulation in the axonal cytoplasm. Resultant reverse operation of sodiumâcalcium exchanger to restore ionic gradients could lead to cytoplasmic calcium accumulation, activation of calpains, and proteolysis of cytoskeleton.",
      "key": "329e8c7f391dac7979d022b5560c7115",
      "line": 143,
      "relation": "increases",
      "source": 27,
      "target": 0,
      "target_modifier": {
        "location": {
          "name": "axon cytoplasm",
          "namespace": "GO"
        }
      }
    },
    {
      "annotations": {
        "CellStructure": [
          {
            "identifier": "Axons",
            "namespace": "CellStructure"
          }
        ],
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "first": "Brownlee WJ",
        "identifier": "27889190",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "namespace": "pubmed",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "In some demyelinated axons, saltatory nerve-impulse conduction is replaced by continuous conduction, which restores function but increases energy demand and sodium accumulation in the axonal cytoplasm. Resultant reverse operation of sodiumâcalcium exchanger to restore ionic gradients could lead to cytoplasmic calcium accumulation, activation of calpains, and proteolysis of cytoskeleton.",
      "key": "5468ad7ab70bdc3542535509e78f6e38",
      "line": 144,
      "relation": "increases",
      "source": 0,
      "source_modifier": {
        "location": {
          "name": "axon cytoplasm",
          "namespace": "GO"
        }
      },
      "target": 30,
      "target_modifier": {
        "modifier": "Activity"
      }
    },
    {
      "annotations": {
        "CellStructure": [
          {
            "identifier": "Axons",
            "namespace": "CellStructure"
          }
        ],
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "first": "Brownlee WJ",
        "identifier": "27889190",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "namespace": "pubmed",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "In some demyelinated axons, saltatory nerve-impulse conduction is replaced by continuous conduction, which restores function but increases energy demand and sodium accumulation in the axonal cytoplasm. Resultant reverse operation of sodiumâcalcium exchanger to restore ionic gradients could lead to cytoplasmic calcium accumulation, activation of calpains, and proteolysis of cytoskeleton.",
      "key": "afe1a8e94d12b3f963f550fb9c8c2adc",
      "line": 146,
      "relation": "decreases",
      "source": 0,
      "source_modifier": {
        "location": {
          "name": "axon cytoplasm",
          "namespace": "GO"
        }
      },
      "target": 4
    },
    {
      "annotations": {
        "CellStructure": [
          {
            "identifier": "Axons",
            "namespace": "CellStructure"
          }
        ],
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "first": "Brownlee WJ",
        "identifier": "27889190",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "namespace": "pubmed",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "In some demyelinated axons, saltatory nerve-impulse conduction is replaced by continuous conduction, which restores function but increases energy demand and sodium accumulation in the axonal cytoplasm. Resultant reverse operation of sodiumâcalcium exchanger to restore ionic gradients could lead to cytoplasmic calcium accumulation, activation of calpains, and proteolysis of cytoskeleton.",
      "key": "3020fa54197c69b2ef36913c2e34172d",
      "line": 145,
      "relation": "decreases",
      "source": 30,
      "source_modifier": {
        "modifier": "Activity"
      },
      "target": 4
    },
    {
      "annotations": {
        "CellStructure": [
          {
            "identifier": "Axons",
            "namespace": "CellStructure"
          }
        ],
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "first": "Brownlee WJ",
        "identifier": "27889190",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "namespace": "pubmed",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "Mitochondrial dysfunction in axons seems to result from impaired mitochondrial transport, susceptibility to oxidative injury, and mutations in mitochondrial DNA, all of which lead to impaired energy production and generation of reactive oxygen species.",
      "key": "80dd227ad581c0d8f73e2c1d126a65aa",
      "line": 151,
      "relation": "negativeCorrelation",
      "source": 17,
      "target": 32
    },
    {
      "annotations": {
        "CellStructure": [
          {
            "identifier": "Axons",
            "namespace": "CellStructure"
          }
        ],
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "first": "Brownlee WJ",
        "identifier": "27889190",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "namespace": "pubmed",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "Mitochondrial dysfunction in axons seems to result from impaired mitochondrial transport, susceptibility to oxidative injury, and mutations in mitochondrial DNA, all of which lead to impaired energy production and generation of reactive oxygen species.",
      "key": "c34a46097eed02955411ce13fc5cd1e8",
      "line": 151,
      "relation": "negativeCorrelation",
      "source": 32,
      "target": 17
    },
    {
      "annotations": {
        "CellStructure": [
          {
            "identifier": "Axons",
            "namespace": "CellStructure"
          }
        ],
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "first": "Brownlee WJ",
        "identifier": "27889190",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "namespace": "pubmed",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "Mitochondrial dysfunction in axons seems to result from impaired mitochondrial transport, susceptibility to oxidative injury, and mutations in mitochondrial DNA, all of which lead to impaired energy production and generation of reactive oxygen species.",
      "key": "08fc87b938bb7e66652fc3e236a9ed91",
      "line": 152,
      "relation": "increases",
      "source": 32,
      "target": 46
    },
    {
      "annotations": {
        "CellStructure": [
          {
            "identifier": "Axons",
            "namespace": "CellStructure"
          },
          {
            "identifier": "Mitochondria",
            "namespace": "CellStructure"
          }
        ],
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "first": "Brownlee WJ",
        "identifier": "27889190",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "namespace": "pubmed",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "Mitochondrial dysfunction in axons seems to result from impaired mitochondrial transport, susceptibility to oxidative injury, and mutations in mitochondrial DNA, all of which lead to impaired energy production and generation of reactive oxygen species.",
      "key": "81acc9c12b72a4ec3e96f7c2f5697464",
      "line": 155,
      "relation": "increases",
      "source": 32,
      "target": 44
    },
    {
      "annotations": {
        "CellStructure": [
          {
            "identifier": "Axons",
            "namespace": "CellStructure"
          },
          {
            "identifier": "Mitochondria",
            "namespace": "CellStructure"
          }
        ],
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "first": "Brownlee WJ",
        "identifier": "27889190",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "namespace": "pubmed",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "Mitochondrial dysfunction in axons seems to result from impaired mitochondrial transport, susceptibility to oxidative injury, and mutations in mitochondrial DNA, all of which lead to impaired energy production and generation of reactive oxygen species.",
      "key": "2b65b3c1363be6c8a464d495a3168506",
      "line": 156,
      "relation": "decreases",
      "source": 44,
      "target": 22
    },
    {
      "annotations": {
        "CellStructure": [
          {
            "identifier": "Axons",
            "namespace": "CellStructure"
          },
          {
            "identifier": "Mitochondria",
            "namespace": "CellStructure"
          }
        ],
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "first": "Brownlee WJ",
        "identifier": "27889190",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "namespace": "pubmed",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "Mitochondrial dysfunction in axons seems to result from impaired mitochondrial transport, susceptibility to oxidative injury, and mutations in mitochondrial DNA, all of which lead to impaired energy production and generation of reactive oxygen species.",
      "key": "61a80ee7cafbc83664958d48fc2bbb42",
      "line": 157,
      "relation": "increases",
      "source": 44,
      "target": 8
    },
    {
      "annotations": {
        "Anatomy": [
          {
            "identifier": "brain",
            "namespace": "Anatomy"
          }
        ],
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "first": "Brownlee WJ",
        "identifier": "27889190",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "namespace": "pubmed",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "Whole-brain atrophy correlates with physical [20] and cognitive [21] impairment.",
      "key": "35f6a6bc84c36620ddf8eec18077b14e",
      "line": 164,
      "relation": "decreases",
      "source": 48,
      "target": 18
    },
    {
      "annotations": {
        "Anatomy": [
          {
            "identifier": "brain",
            "namespace": "Anatomy"
          },
          {
            "identifier": "cortex",
            "namespace": "Anatomy"
          }
        ],
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "first": "Brownlee WJ",
        "identifier": "27889190",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "namespace": "pubmed",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "Cortical atrophy is prominent in progressive multiple sclerosis [26] and correlates with physical [27] and cognitive [28] impairment.",
      "key": "d6a016dfc5d5fafb9987254ed66552ab",
      "line": 172,
      "relation": "decreases",
      "source": 48,
      "target": 18
    },
    {
      "annotations": {
        "Anatomy": [
          {
            "identifier": "brain",
            "namespace": "Anatomy"
          }
        ],
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "first": "Brownlee WJ",
        "identifier": "27889190",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "namespace": "pubmed",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "Whole-brain atrophy correlates with physical [20] and cognitive [21] impairment.",
      "key": "0e0a2ebbac9b1881089e491a5036a827",
      "line": 165,
      "relation": "increases",
      "source": 48,
      "target": 45
    },
    {
      "annotations": {
        "Anatomy": [
          {
            "identifier": "brain",
            "namespace": "Anatomy"
          },
          {
            "identifier": "cortex",
            "namespace": "Anatomy"
          }
        ],
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "first": "Brownlee WJ",
        "identifier": "27889190",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "namespace": "pubmed",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "Cortical atrophy is prominent in progressive multiple sclerosis [26] and correlates with physical [27] and cognitive [28] impairment.",
      "key": "5a4545c8d1df10cd7c84cc27c1cd4d88",
      "line": 173,
      "relation": "increases",
      "source": 48,
      "target": 45
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "MeSHAnatomy": [
          {
            "identifier": "Spinal Cord",
            "namespace": "MeSHAnatomy"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "first": "Brownlee WJ",
        "identifier": "27889190",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "namespace": "pubmed",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "Spinal cord atrophy correlates with clinical measures of disability.[35]",
      "key": "2646e95b0e1aac304d30668314da1625",
      "line": 187,
      "relation": "increases",
      "source": 48,
      "target": 52
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "MeSHDisease": [
          {
            "identifier": "Multiple Sclerosis, Relapsing-Remitting",
            "namespace": "MeSHDisease"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "first": "Brownlee WJ",
        "identifier": "27889190",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "namespace": "pubmed",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "Fingolimod reduced relapses, MRI lesion activity, and brain volume loss in three phase 3 trials in relapsing-remitting multiple sclerosis.[56â58]",
      "key": "e850962cf439eb17d318005094db0d9a",
      "line": 195,
      "relation": "decreases",
      "source": 3,
      "target": 50
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "MeSHDisease": [
          {
            "identifier": "Multiple Sclerosis, Relapsing-Remitting",
            "namespace": "MeSHDisease"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "first": "Brownlee WJ",
        "identifier": "27889190",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "namespace": "pubmed",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "Fingolimod reduced relapses, MRI lesion activity, and brain volume loss in three phase 3 trials in relapsing-remitting multiple sclerosis.[56â58]",
      "key": "9fa742a92621a2b08d87e36d52e427cb",
      "line": 196,
      "relation": "decreases",
      "source": 3,
      "target": 53
    },
    {
      "key": "02dc2a65521964be0f3de36cbceb72d3",
      "relation": "partOf",
      "source": 3,
      "target": 26
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "MeSHDisease": [
          {
            "identifier": "Multiple Sclerosis, Relapsing-Remitting",
            "namespace": "MeSHDisease"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "first": "Brownlee WJ",
        "identifier": "27889190",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "namespace": "pubmed",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "Fingolimod readily enters the brain and has direct effects on several CNS cell types mediated by sphingosine 1-phosphate receptors, suggesting it might be beneficial in progressive multiple sclerosis.[59]",
      "key": "01763df46849a6b117db7a056150f2fa",
      "line": 201,
      "relation": "association",
      "source": 26,
      "target": 37
    },
    {
      "key": "4ed6a94c05a87e96d3bbcc95cc9f6ff9",
      "relation": "partOf",
      "source": 29,
      "target": 26
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "MeSHDisease": [
          {
            "identifier": "Multiple Sclerosis, Relapsing-Remitting",
            "namespace": "MeSHDisease"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "first": "Brownlee WJ",
        "identifier": "27889190",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "namespace": "pubmed",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "Fingolimod readily enters the brain and has direct effects on several CNS cell types mediated by sphingosine 1-phosphate receptors, suggesting it might be beneficial in progressive multiple sclerosis.[59]",
      "key": "c61f5a341f5ab8adefc751b4141e76dc",
      "line": 201,
      "relation": "association",
      "source": 37,
      "target": 26
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "MeSHDisease": [
          {
            "identifier": "Multiple Sclerosis, Relapsing-Remitting",
            "namespace": "MeSHDisease"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "first": "Brownlee WJ",
        "identifier": "27889190",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "namespace": "pubmed",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "The vitamin biotin is a coenzyme for many essential carboxylases and, in high doses, is hypothesised to enhance cellular energy production with resultant improved axonal function, decreased neurodegeneration, and enhanced remyelination.[65]",
      "key": "634fb881da43a1cc9351efbedf3cf417",
      "line": 211,
      "relation": "increases",
      "source": 1,
      "target": 22
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "MeSHDisease": [
          {
            "identifier": "Multiple Sclerosis, Relapsing-Remitting",
            "namespace": "MeSHDisease"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "first": "Brownlee WJ",
        "identifier": "27889190",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "namespace": "pubmed",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "The vitamin biotin is a coenzyme for many essential carboxylases and, in high doses, is hypothesised to enhance cellular energy production with resultant improved axonal function, decreased neurodegeneration, and enhanced remyelination.[65]",
      "key": "f895744160cd6642db576d321e3f420e",
      "line": 212,
      "relation": "increases",
      "source": 1,
      "target": 9,
      "target_modifier": {
        "modifier": "Activity"
      }
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "MeSHDisease": [
          {
            "identifier": "Multiple Sclerosis, Relapsing-Remitting",
            "namespace": "MeSHDisease"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "first": "Brownlee WJ",
        "identifier": "27889190",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "namespace": "pubmed",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "The vitamin biotin is a coenzyme for many essential carboxylases and, in high doses, is hypothesised to enhance cellular energy production with resultant improved axonal function, decreased neurodegeneration, and enhanced remyelination.[65]",
      "key": "577a76eecbb205e445e37ceb4dca3b78",
      "line": 213,
      "relation": "decreases",
      "source": 1,
      "target": 33
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "MeSHDisease": [
          {
            "identifier": "Multiple Sclerosis, Relapsing-Remitting",
            "namespace": "MeSHDisease"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "first": "Brownlee WJ",
        "identifier": "27889190",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "namespace": "pubmed",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "The vitamin biotin is a coenzyme for many essential carboxylases and, in high doses, is hypothesised to enhance cellular energy production with resultant improved axonal function, decreased neurodegeneration, and enhanced remyelination.[65]",
      "key": "bb710f3223f3d59f42853b633590a261",
      "line": 214,
      "relation": "increases",
      "source": 1,
      "target": 25
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "MeSHDisease": [
          {
            "identifier": "Multiple Sclerosis, Relapsing-Remitting",
            "namespace": "MeSHDisease"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "first": "Brownlee WJ",
        "identifier": "27889190",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "namespace": "pubmed",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "LINGO-1 is a protein expressed by oligodendrocytes and neurons that inhibits remyelination.[66]",
      "key": "e90849d92df097fe3ccf2892b77c1f09",
      "line": 219,
      "relation": "increases",
      "source": 12,
      "target": 28
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "MeSHDisease": [
          {
            "identifier": "Multiple Sclerosis, Relapsing-Remitting",
            "namespace": "MeSHDisease"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "first": "Brownlee WJ",
        "identifier": "27889190",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "namespace": "pubmed",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "LINGO-1 is a protein expressed by oligodendrocytes and neurons that inhibits remyelination.[66]",
      "key": "e72ab66320815eddc890b75573de7654",
      "line": 221,
      "relation": "increases",
      "source": 12,
      "target": 25
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "MeSHDisease": [
          {
            "identifier": "Multiple Sclerosis, Relapsing-Remitting",
            "namespace": "MeSHDisease"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "first": "Brownlee WJ",
        "identifier": "27889190",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "namespace": "pubmed",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "LINGO-1 is a protein expressed by oligodendrocytes and neurons that inhibits remyelination.[66]",
      "key": "352ba418dd98b8084d4f14643c147025",
      "line": 220,
      "relation": "increases",
      "source": 11,
      "target": 28
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "MeSHDisease": [
          {
            "identifier": "Multiple Sclerosis, Relapsing-Remitting",
            "namespace": "MeSHDisease"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "first": "Brownlee WJ",
        "identifier": "27889190",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "namespace": "pubmed",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "LINGO-1 is a protein expressed by oligodendrocytes and neurons that inhibits remyelination.[66]",
      "key": "af7a6b7a8805e0cbcd950f29e4102625",
      "line": 222,
      "relation": "increases",
      "source": 11,
      "target": 25
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "MeSHDisease": [
          {
            "identifier": "Multiple Sclerosis",
            "namespace": "MeSHDisease"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "first": "Brownlee WJ",
        "identifier": "27889190",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "namespace": "pubmed",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "A pilot study of clemastine showed improvement on visual evoked potentials in participants with multiple sclerosis-related chronic optic neuropathy.[73]",
      "key": "aa6dbf6f19a36618f89a415b0c222424",
      "line": 228,
      "relation": "increases",
      "source": 2,
      "target": 24
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "MeSHDisease": [
          {
            "identifier": "Multiple Sclerosis",
            "namespace": "MeSHDisease"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Brownlee WJ",
          "Fazekas F",
          "Hardy TA",
          "Miller DH"
        ],
        "date": "2017-04-01",
        "first": "Brownlee WJ",
        "identifier": "27889190",
        "journal": "Lancet (London, England)",
        "last": "Miller DH",
        "name": "Diagnosis of multiple sclerosis: progress and challenges.",
        "namespace": "pubmed",
        "pages": "1336-1346",
        "volume": "389"
      },
      "evidence": "A pilot study of clemastine showed improvement on visual evoked potentials in participants with multiple sclerosis-related chronic optic neuropathy.[73]",
      "key": "a98c2ea969180b75006a9a924f0637f2",
      "line": 229,
      "relation": "increases",
      "source": 2,
      "target": 19
    }
  ],
  "multigraph": true,
  "nodes": [
    {
      "bel": "a(CHEBI:\"calcium cation\")",
      "concept": {
        "name": "calcium cation",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "843ecb28e813dc0ee53e75bc5c86e613"
    },
    {
      "bel": "a(CHEBI:biotin)",
      "concept": {
        "name": "biotin",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "c0a2eff81e9acad15eadaf9f20b03bf3"
    },
    {
      "bel": "a(DRUGBANK:Clemastine)",
      "concept": {
        "name": "Clemastine",
        "namespace": "DRUGBANK"
      },
      "function": "Abundance",
      "id": "20333e3bbad007ae2a71316f68586203"
    },
    {
      "bel": "a(DRUGBANK:Fingolimod)",
      "concept": {
        "name": "Fingolimod",
        "namespace": "DRUGBANK"
      },
      "function": "Abundance",
      "id": "de33bded27be2c6871c8e342da56fc38"
    },
    {
      "bel": "a(GO:cytoskeleton)",
      "concept": {
        "name": "cytoskeleton",
        "namespace": "GO"
      },
      "function": "Abundance",
      "id": "51ad31d28e474c33008791d4c056bf13"
    },
    {
      "bel": "a(MESH:\"Blood-Brain Barrier\")",
      "concept": {
        "name": "Blood-Brain Barrier",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "63dcf0f7f45e2c3862eb5a77da5f2627"
    },
    {
      "bel": "a(MESH:\"Gray Matter\")",
      "concept": {
        "name": "Gray Matter",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "ec3d8cd3fe21e400949f6f15da400cd6"
    },
    {
      "bel": "a(MESH:\"Presynaptic Terminals\")",
      "concept": {
        "name": "Presynaptic Terminals",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "f933852454994d439499af0b968da5b8"
    },
    {
      "bel": "a(MESH:\"Reactive Oxygen Species\")",
      "concept": {
        "name": "Reactive Oxygen Species",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "dd0e798c738472fa8ffb9fa88a2eacc7"
    },
    {
      "bel": "a(MESH:Axons)",
      "concept": {
        "name": "Axons",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "438b15a6e68338bcf5615b067cf5d271"
    },
    {
      "bel": "a(MESH:Neurites)",
      "concept": {
        "name": "Neurites",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "192f89a6158de53e2d132cdabb1553da"
    },
    {
      "bel": "a(MESH:Neurons)",
      "concept": {
        "name": "Neurons",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "c429b8780142c504cf23cacfc2fa2b09"
    },
    {
      "bel": "a(MESH:Oligodendroglia)",
      "concept": {
        "name": "Oligodendroglia",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "828404c8a29719c3b6437908364a6ddd"
    },
    {
      "bel": "a(MESH:Sodium)",
      "concept": {
        "name": "Sodium",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "9b2c5dccd06f60600bf4e1ecb40cbaea"
    },
    {
      "bel": "bp(GO:\"B cell activation\")",
      "concept": {
        "name": "B cell activation",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "b8c0c901f2d5cd6008437d007903dccb"
    },
    {
      "bel": "bp(GO:\"T cell activation\")",
      "concept": {
        "name": "T cell activation",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "6475795284a1f1c537342febd590bb31"
    },
    {
      "bel": "bp(GO:\"microglial cell activation\")",
      "concept": {
        "name": "microglial cell activation",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "3c02f523866973a040dc6bfa5b372b2e"
    },
    {
      "bel": "bp(GO:\"mitochondrial transport\")",
      "concept": {
        "name": "mitochondrial transport",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "fe54bc53eaa9419f7d3745d6f65201bf"
    },
    {
      "bel": "bp(GO:cognition)",
      "concept": {
        "name": "cognition",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "24220ec2073c35bcd945681ee9c6ea38"
    },
    {
      "bel": "bp(HP:\"Optic neuropathy\")",
      "concept": {
        "name": "Optic neuropathy",
        "namespace": "HP"
      },
      "function": "BiologicalProcess",
      "id": "6fc877cd096a5654678489b6fb82f2e0"
    },
    {
      "bel": "bp(MESH:\"Axonal Transport\")",
      "concept": {
        "name": "Axonal Transport",
        "namespace": "MESH"
      },
      "function": "BiologicalProcess",
      "id": "d04aee60fa1a8ead109b6583c1b4e711"
    },
    {
      "bel": "bp(MESH:\"Cell Death\")",
      "concept": {
        "name": "Cell Death",
        "namespace": "MESH"
      },
      "function": "BiologicalProcess",
      "id": "fdcf9ec5fc3c984c45cd62abeab40dc0"
    },
    {
      "bel": "bp(MESH:\"Energy Metabolism\")",
      "concept": {
        "name": "Energy Metabolism",
        "namespace": "MESH"
      },
      "function": "BiologicalProcess",
      "id": "5aaa959e5040d4765b684841ad0942e1"
    },
    {
      "bel": "bp(MESH:\"Neural Conduction\")",
      "concept": {
        "name": "Neural Conduction",
        "namespace": "MESH"
      },
      "function": "BiologicalProcess",
      "id": "85d7660e247fcbcf3c463be4a1810d4a"
    },
    {
      "bel": "bp(MESH:\"Vision, Ocular\")",
      "concept": {
        "name": "Vision, Ocular",
        "namespace": "MESH"
      },
      "function": "BiologicalProcess",
      "id": "b2d2eeef24c19bd5e81b58eb4b551a74"
    },
    {
      "bel": "bp(MESH:Remyelination)",
      "concept": {
        "name": "Remyelination",
        "namespace": "MESH"
      },
      "function": "BiologicalProcess",
      "id": "79abdcab21f9bd75b3078b78620119b0"
    },
    {
      "bel": "complex(a(DRUGBANK:Fingolimod), p(HGNCGENEFAMILY:\"Sphingosine 1-phosphate receptors\"))",
      "function": "Complex",
      "id": "2741d3454539bb09faeb9b5795a36fe4",
      "members": [
        {
          "bel": "a(DRUGBANK:Fingolimod)",
          "concept": {
            "name": "Fingolimod",
            "namespace": "DRUGBANK"
          },
          "function": "Abundance",
          "id": "de33bded27be2c6871c8e342da56fc38"
        },
        {
          "bel": "p(HGNCGENEFAMILY:\"Sphingosine 1-phosphate receptors\")",
          "concept": {
            "name": "Sphingosine 1-phosphate receptors",
            "namespace": "HGNCGENEFAMILY"
          },
          "function": "Protein",
          "id": "e1d36600ec3ae163d5c1f044a7eae6ee"
        }
      ]
    },
    {
      "bel": "composite(a(MESH:Sodium), p(MESH:\"Sodium-Calcium Exchanger\"))",
      "function": "Composite",
      "id": "178baa049fae0993df122c2e0b5495b8",
      "members": [
        {
          "bel": "a(MESH:Sodium)",
          "concept": {
            "name": "Sodium",
            "namespace": "MESH"
          },
          "function": "Abundance",
          "id": "9b2c5dccd06f60600bf4e1ecb40cbaea"
        },
        {
          "bel": "p(MESH:\"Sodium-Calcium Exchanger\")",
          "concept": {
            "name": "Sodium-Calcium Exchanger",
            "namespace": "MESH"
          },
          "function": "Protein",
          "id": "34b7b8e6e01ecbc80f57cfbe123a4fbc"
        }
      ]
    },
    {
      "bel": "p(HGNC:LINGO1)",
      "concept": {
        "name": "LINGO1",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "5293ae73db034f03a25a047ae2a76e4c"
    },
    {
      "bel": "p(HGNCGENEFAMILY:\"Sphingosine 1-phosphate receptors\")",
      "concept": {
        "name": "Sphingosine 1-phosphate receptors",
        "namespace": "HGNCGENEFAMILY"
      },
      "function": "Protein",
      "id": "e1d36600ec3ae163d5c1f044a7eae6ee"
    },
    {
      "bel": "p(HGNCGENEFAMILY:Calpains)",
      "concept": {
        "name": "Calpains",
        "namespace": "HGNCGENEFAMILY"
      },
      "function": "Protein",
      "id": "7ca722526fc0d17a88d8dc58f35706a6"
    },
    {
      "bel": "p(MESH:\"Sodium-Calcium Exchanger\")",
      "concept": {
        "name": "Sodium-Calcium Exchanger",
        "namespace": "MESH"
      },
      "function": "Protein",
      "id": "34b7b8e6e01ecbc80f57cfbe123a4fbc"
    },
    {
      "bel": "path(CONSO:\"mitochondrial dysfunction\")",
      "concept": {
        "name": "mitochondrial dysfunction",
        "namespace": "CONSO"
      },
      "function": "Pathology",
      "id": "14a330b2e354b7af4f380b05664a5728"
    },
    {
      "bel": "path(CONSO:Neurodegeneration)",
      "concept": {
        "name": "Neurodegeneration",
        "namespace": "CONSO"
      },
      "function": "Pathology",
      "id": "e18248b0d7323caa29b448e45437a1e5"
    },
    {
      "bel": "path(DOID:\"multiple sclerosis\")",
      "concept": {
        "name": "multiple sclerosis",
        "namespace": "DOID"
      },
      "function": "Pathology",
      "id": "828e65d53fe5c29b364f79cfd5304f90"
    },
    {
      "bel": "path(DOID:\"primary progressive multiple sclerosis\")",
      "concept": {
        "name": "primary progressive multiple sclerosis",
        "namespace": "DOID"
      },
      "function": "Pathology",
      "id": "bc354c4df683e76d8f33dad953c46827"
    },
    {
      "bel": "path(DOID:\"progressive relapsing multiple sclerosis\")",
      "concept": {
        "name": "progressive relapsing multiple sclerosis",
        "namespace": "DOID"
      },
      "function": "Pathology",
      "id": "6911d1dc25a970713114a8a92f038cbe"
    },
    {
      "bel": "path(DOID:\"relapsing-remitting multiple sclerosis\")",
      "concept": {
        "name": "relapsing-remitting multiple sclerosis",
        "namespace": "DOID"
      },
      "function": "Pathology",
      "id": "b21b34dd5c948d6330eceb5f4eb9649f"
    },
    {
      "bel": "path(DOID:\"secondary progressive multiple sclerosis\")",
      "concept": {
        "name": "secondary progressive multiple sclerosis",
        "namespace": "DOID"
      },
      "function": "Pathology",
      "id": "38f0567d9ceb0ade6bf93de56a897396"
    },
    {
      "bel": "path(GO:cognition)",
      "concept": {
        "name": "cognition",
        "namespace": "GO"
      },
      "function": "Pathology",
      "id": "1c1714014427bf1244c4bc1ec777b694"
    },
    {
      "bel": "path(HP:\"CNS demyelination\")",
      "concept": {
        "name": "CNS demyelination",
        "namespace": "HP"
      },
      "function": "Pathology",
      "id": "fb7670f43e6511eda6fbd0b0517820a6"
    },
    {
      "bel": "path(HP:Ataxia)",
      "concept": {
        "name": "Ataxia",
        "namespace": "HP"
      },
      "function": "Pathology",
      "id": "da410da3fc48fdd33615f068787f9705"
    },
    {
      "bel": "path(HP:Hemiparesis)",
      "concept": {
        "name": "Hemiparesis",
        "namespace": "HP"
      },
      "function": "Pathology",
      "id": "9abd8c6c941cad4d9ecf8178e74ccfd4"
    },
    {
      "bel": "path(HP:Myelopathy)",
      "concept": {
        "name": "Myelopathy",
        "namespace": "HP"
      },
      "function": "Pathology",
      "id": "0e8e666aba2c122916e2509d0a34946d"
    },
    {
      "bel": "path(MESH:\"DNA Damage\")",
      "concept": {
        "name": "DNA Damage",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "21c7af2e646347699cc2f61cb7ab8225"
    },
    {
      "bel": "path(MESH:\"Motor Disorders\")",
      "concept": {
        "name": "Motor Disorders",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "2e3b041e894813b580bde665989837d0"
    },
    {
      "bel": "path(MESH:\"Oxidative Stress\")",
      "concept": {
        "name": "Oxidative Stress",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "5d5071d9dea362c9b9b6ee5de9eb67be"
    },
    {
      "bel": "path(MESH:\"Vision Disorders\")",
      "concept": {
        "name": "Vision Disorders",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "83a250aaf35ebb80bc12673253363fb5"
    },
    {
      "bel": "path(MESH:Atrophy)",
      "concept": {
        "name": "Atrophy",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "7d5394b2784c6e661c25500d859dc266"
    },
    {
      "bel": "path(MESH:Meningitis)",
      "concept": {
        "name": "Meningitis",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "de1b8fae2c3475b6d223ff0982fea7bf"
    },
    {
      "bel": "path(MESH:Recurrence)",
      "concept": {
        "name": "Recurrence",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "aa96a379e06d692c47a017c1b23ad98f"
    },
    {
      "bel": "path(NCIT:C117277)",
      "concept": {
        "name": "C117277",
        "namespace": "NCIT"
      },
      "function": "Pathology",
      "id": "24ca02ad1b4993ba4c5c0242df655c6d"
    },
    {
      "bel": "path(NCIT:C21007)",
      "concept": {
        "name": "C21007",
        "namespace": "NCIT"
      },
      "function": "Pathology",
      "id": "567e9969f4afcd1025c406a11302125a"
    },
    {
      "bel": "path(NCIT:C3824)",
      "concept": {
        "name": "C3824",
        "namespace": "NCIT"
      },
      "function": "Pathology",
      "id": "ff31f470d2de26c1af1f1301d4a050d0"
    }
  ]
}